Abstract
Introduction

Tissue engineering (TE) represents a scientific approach focussing on the emulation of neo-organogenesis [1]. Research interest focuses on a variety of different tissues that might be recreated for replacement of lost tissues. After loss of skeletal muscle tissue new solutions might be brought about for the treatment of a variety of muscle diseases, including skeletal myopathies such as muscular dystrophy or spinal muscular atrophy
. Furthermore localized loss of skeletal muscle tissue, as a result of traumatic injury, aggressive tumour ablation or prolonged denervation, e.g. are common clinical problems. In the last years, important developments have changed the field of skeletal muscle TE [4, 5] .
Since Vandenburgh et al. introduced the 3D cultivation of primary myoblasts in collagen gel and generated contracting muscle tissue in vitro for the first time in 1988 [6] , there have been developments in the field of skeletal muscle TE and new approaches and techniques have emerged. However, collagen as well as fibrin gels have proven unsuitable for TE due to their fast degradation in vitro [7] . With regard to material science, recent developments in the field of nanotechnology have brought up new possibilities which will be highlighted in this review. Two years after Vandenburgh' s 3D cultivation of myoblasts in collagen gels, Strohman and colleagues showed that monolayers of differentiating myoblasts detached from the membrane and formed 3D and contractible muscle tissues termed myooids [8] . Though the method of generating myooids was brought to perfection by Dennis and coworkers, the in vitro engineered muscle constructs did not exceed a diameter of 1 mm [9] . These in vitro studies led to a better understanding of myogenic differentiation and contractility. Yet [11] [12] . The prevascularized constructs showed less apoptosis of myoblasts after transplantation in vivo [12] . However, in clinical application, the transfer of larger muscle constructs to the site of the defect requires an axial vascularization of the engineered muscle tissue. Furthermore, the use of embryonic cell sources is a critical issue in medical as well as in ethical terms. Therefore, several in vivo studies [13] [14] [15] have used the microsurgical AV-loop model in the rat first described by Erol and Spira in 1980 [16] to generate an axial vascularization. In combination with secondary cell transfer to axially pre-vascularized matrices this well-established model might be the most promising step towards a future application of large tissue-engineered constructs in a clinical scenario [17] . Recently, the rat AV-loop model was translated into the sheep AVloop model for large constructs [18] [19] 
Matrices for skeletal muscle tissue engineering -gaining orientation
Regarding the architecture, matrices can be divided into randomly orientated scaffolds and matrices with a certain alignment (Fig. 1) [23] or generating micropatterned moulds and casting the liquid matrix material onto the mould as described by Walboomers and others [24] [25] . The fabrication of micropatterned matrices has been developed for in vitro analysis of cell behaviour and differentiation on aligned surfaces and showed orientated cell growth of, e.g. fibroblasts [26] [27] , myoblasts [28] and neural cells [29] [30] along the microgrooves. This phenomenon commonly termed as 'cell guidance theory' [24, 31] encourages and facilitates myogenic differentiation in vitro [32] . Flaibani [33] . This setting increased the myogenic differentiation of myoblasts even more than cultivation on micropatterned membranes without electrical stimuli [33] . Though [34] [35] . This method allows a fine adjustment of the average pore size by varying the freezing temperature [36] . A variety of different synthetic as well as biological materials can be processed as hydrogels by freeze-drying, e.g. collagen [34] , fibroin [37] and composites [38] . Though these matrices have no limitations in their 3D size, the thickness and structure of matrix material between the pores is hardly controllable by the freeze-drying method. Therefore, further adjustments of the matrices including coating for controlled degradation or drug release as well as surface modification remain a challenge.
and coworkers analysed electrical stimulation in addition to microgrooved poly-(L-lacticacid) membranes on the differentiation of muscle precursor cells
Electrospun nanofibre matrices
The electrospinning technique principally uses electrical voltage to form fibres in the range of micrometers down to a few nanometres. Though simple in its principle, electrospinning is a complex process that depends on a variety of parameters. This complexity elicits a tremendous spectrum of applications and variety of possibilities to adjust matrix properties as desired [39] . A great diversity of synthetic polymers as well as biopolymers can be used to generate electrospun nanofibres including proteins of the natural ECM such as collagen [40] [41] , elastin [40] [41] and hyaluronic acid [42] . Matrices composed of electrospun ECM proteins uniquely mimic the structure of the natural ECM which is of utmost importance for attachment, viability and differentiation of cells seeded into nanofibrous matrices [43] [44] [45] . The aforementioned advantages of biopolymers are often combined with the higher stability of synthetic polymers such as poly-(epsilon-caprolactone). Matrices solely composed of synthetic polymers, e.g. PCL [46] or poly-(ester-urethanex) [47] [48] .
As mentioned before, nanofibre matrices with parallel alignment (Figs. 3 and 4) prove as ideal scaffolds for cultivating myoblasts [49] . The generation of parallel fibre alignment can be easily achieved by using a rotating mandrel to collect the nanofibres [50] . However, the pore sizes of electrospun matrices with parallel fibre alignment are hardly controllable and have ever been a great challenge. Therefore, electrospinning of aligned nanofibres into 3D scaffolds usually results in densely packed nanofibres [51] leading to poor cell infiltration of slow degradable nanofibrous scaffolds in vitro and in vivo [52] . Baker and coworkers have introduced the method of co-spinning sacrificial fibres into 3D aligned nanofibre matrices [53] . The sacrificial fibres, e.g. water-soluble poly-(ethylene-oxide), are leached out after electrospinning and leave behind interspaces where cells can easily pass through [53] . Thus the interspaces between the aligned nanofibres can be augmented without increasing the fibre diameter.
Nanotechnology and smart matrices
The core-shell technique can also be used as drug delivery system (DDS), which has opened up a new opportunity to tailor 'smart' scaffolds with controllable drug release [54] [55] . Nanoparticles and nanofibre matrices as drug delivery devices are an immensely emerging field in pharmacotherapy as well as for TE [56] . In case of Duchenne muscular dystrophy, the application of nanopolymer as DDS has already reached the stage of phase I clinical trials [57] [58] . Nanofibre matrices as DDS also enable the administration of growth factors [59] , angiogenic factors like VEGF [60] [61] , which can reduce the time of pre-vascularization of implanted matrices in vivo [62] as well as factors to enforce and promote cell differentiation. Regarding skeletal muscle TE, different factors are known to induce myoblast proliferation and myogenic differentiation, e.g. insulin-like growth factor-1 [63] , nerve growth factor [64] [65] or the synthetic pyrimidine MS-818 which is known as a neurotrophic factor but also accelerates muscle regeneration [66] .
Smart nanofibrous matrices with controlled release of specific growth factors have already proven their potential in other fields
of TE [67] [68] Alternatively, electrical stimulation is a well-known factor for inducing differentiation in myoblasts [69] as well as cardiomyocytes in vitro [70] . Shafy [75] .
et al. proved that simultaneous implantation of a pacemaker along with myoblasts into infarcted myocard of sheep had a positive influence on differentiation of implanted myoblasts and led to better myocardial function [71]. As an alternative to the commonly used external electrical stimulation, Gaetani and coworkers analysed the influence of extremely lowfrequency electromagnetic fields (ELF-EMF) on cardiac stem cells [72]. Their results show that exposure of cells to ELF-EMFs can induce differentiation of cardiac stem cells. Thus, the use of EMF could replace the implantation of pacemakers. The electrospinning technique also provides the opportunity to generate electrically conductive matrices by spinning conductive polymers, such as poly(aniline) nanofibres (PANi). GhasemiMobarakeh et al. showed that doped PANi blended with PCL and gelatine solution exhibit acceptable cell attachment [73]. Neural stem cells cultured on these PANi/PCL/gelatine-blend nanofibre scaffolds showed increased proliferation and neurite outgrowth when electrical stimulation was applied. A similar setting (PANi/gelatine blend nanofibres) was chosen by Li and coworkers to analyse the behaviour of rat cardiac myoblasts [74] on conductive nanofibrous scaffolds and by Jun and colleagues (poly(lacticepsilon-caprolactone) [PLCL]/PANi blend nanofibres) using C2C12 murine myoblasts. Jun et al. showed that the expression of myogenin, a muscle specific protein that marks early myogenic differentiation, was significantly higher in myoblasts cultured on electrically conductive nanofibrous matrices than in myoblasts cultivated on PLCL scaffolds
Cell sources for skeletal muscle TE
In opposite to the impressive developments in nanotechnology there are still great shortcomings on the cell side. Regarding the cell source, the satellite cell is the most prominent one (Fig. 5 ) [76] [77] [80] . The expression of Myf5 as an initiator of myogenic differentiation [81] marks the commitment of this cell population to the myogenic lineage [80] . [104] . Other methods for cell reprogramming like the use of microRNA are being discussed [105] . Another drawback is the risk of tumorigenicity that arises from the Yamanaka factors themselves because c-Myc and Klf4 are known oncogenes [ [106] [107] . Nagakawa 
